Latest Research

Overview of The Pfizer And BioNTech Vaccine: BNT162b2

Story Highlights
  • The BNT162b2 Vaccine uses relatively novel technology of nucleoside-modified messenger RNA.
  • The effective dosage was the 30µg dose level in a 2 dose schedule.This yielded in mild side effects. 
  • Although,The Pfizer vaccine is a leading candidate,a single vaccine will be an insufficient supply in the initial stages.
You need to login to view this content. Please . Not a Member? Join Us

Related Articles

Back to top button

Important This site makes use of cookies which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies.